Loading insider details...
Beta
Latest Form 4 (Sep 17, 2026): Sale of 100,000 CLYM shares, $1.37M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Climb Bio, Inc. (CLYM) | Sale | 100,000 | $1.37M |
| Jun 8, 2026 | Climb Bio, Inc. (CLYM) | Grant/Award | 40,000 | n/a |
| Feb 27, 2026 | Climb Bio, Inc. (CLYM) | Sale | 33,687 | $236.0K |
| Feb 17, 2026 | Climb Bio, Inc. (CLYM) | Sale | 90,000 | $471.0K |
| Aug 11, 2025 | Climb Bio, Inc. (CLYM) | Grant/Award | 100,375 | n/a |
| Jul 1, 2025 | Climb Bio, Inc. (CLYM) | Exercise/Conversion | 25,094 | n/a |
| Jun 5, 2025 | Climb Bio, Inc. (CLYM) | Grant/Award | 40,000 | n/a |
| Mar 27, 2025 | Climb Bio, Inc. (CLYM) | Exercise/Conversion | 25,093 | n/a |
| Jan 3, 2025 | Climb Bio, Inc. (CLYM) | Exercise/Conversion | 50,188 | n/a |
| Jun 27, 2024 | Eliem Therapeutics, Inc. (ELYM) | Grant/Award | 103,907 | n/a |